Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor.

Summary

Using time-resolved cryo-EM under non-equilibrium conditions, the authors captured structural intermediates during GTP-driven Gαiβγ activation by MOR bound to ligands with partial, full, or super-agonism. The approach provides a structural framework to explain how ligand efficacy maps onto distinct activation trajectories of MOR signaling.

Key Findings

• Time-resolved cryo-EM captured non-equilibrium activation intermediates of MOR-Gαiβγ during GTP loading.
• MOR was studied with ligands exhibiting partial, full, and super-agonism to probe efficacy-dependent activation.
• Findings provide a structural framework to interpret ligand-dependent differences in GPCR signaling efficacy.

Clinical Implications

While not immediately practice-changing, these structural insights can inform rational opioid design to optimize analgesia while minimizing adverse effects.

Limitations

• In vitro structural snapshots may not fully capture cellular signaling dynamics
• Details on functional coupling in living systems require further validation

Future Directions

Integrate structural intermediates with time-resolved biophysics and cellular signaling readouts to map efficacy to functional outcomes; extend to biased agonists relevant to safer analgesia.